AbbVie: The Market Is Getting It Wrong
Source: SeekingAlpha
2026-02-05 08:52:07 ET
It has been quite a while since I've covered AbbVie Inc. ( ABBV ). Back in August of last year, I initiated coverage with a buy rating as earnings were strong and their Rinvoq had new market potential. While the chart below shows that this bullish call worked out alright, it actually hasn't updated to show the stock's selloff after their most recent earnings . The sharp drop has basically erased all gains, and so today, we'll see if the panic is justified or whether this is an opportunity to buy....
Read the full article on Seeking Alpha
For further details see:
AbbVie: The Market Is Getting It Wrong
AbbVie Inc.
NASDAQ: ABBV
ABBV Trading
-0.97% G/L:
$224.48 Last:
1,406,476 Volume:
$226.89 Open:
ABBV Latest News
March 13, 2026 01:36:56 pm
Concorde Financial Exits Howard Hughes Holdings, Developer of Large Sun Belt Communities
ABBV Stock Data
$396,361,630,803
1,749,710,786
N/A
2503
N/A
Pharmaceuticals
Healthcare
US
North Chicago
